Notable Labs, Ltd. (NTBL)
NASDAQ: NTBL · IEX Real-Time Price · USD
0.975
+0.005 (0.52%)
At close: Apr 19, 2024, 4:00 PM
0.980
+0.005 (0.52%)
After-hours: Apr 19, 2024, 7:47 PM EDT
Notable Labs Market Cap
Notable Labs has a market cap or net worth of $8.79 million as of April 19, 2024. Its market cap has decreased by -33.89% in one year.
Market Cap
8.79M
Enterprise Value
-983.20K
1-Year Change
-33.89%
Ranking
Category
Stock Price
$0.98
Market Cap Chart
Since October 1, 2014, Notable Labs's market cap has decreased from $108.40M to $8.79M, a decrease of -91.89%. That is a compound annual growth rate of -23.11%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 19, 2024 | 8.80M | 1.15% |
Apr 18, 2024 | 8.70M | - |
Apr 17, 2024 | 8.70M | -2.25% |
Apr 16, 2024 | 8.90M | -16.04% |
Apr 15, 2024 | 10.60M | 0.95% |
Apr 12, 2024 | 10.50M | -3.67% |
Apr 11, 2024 | 10.90M | -0.91% |
Apr 10, 2024 | 11.00M | -13.39% |
Apr 9, 2024 | 12.70M | -5.22% |
Apr 8, 2024 | 13.40M | -9.46% |
Apr 5, 2024 | 14.80M | -0.67% |
Apr 4, 2024 | 14.90M | -1.97% |
Apr 3, 2024 | 15.20M | 2.70% |
Apr 2, 2024 | 14.80M | -2.63% |
Apr 1, 2024 | 15.20M | -4.40% |
Mar 28, 2024 | 15.90M | -1.85% |
Mar 27, 2024 | 16.20M | 3.18% |
Mar 26, 2024 | 15.70M | - |
Mar 25, 2024 | 15.70M | -8.72% |
Mar 22, 2024 | 17.20M | 11.69% |
Mar 21, 2024 | 15.40M | 6.94% |
Mar 20, 2024 | 14.40M | -3.36% |
Mar 19, 2024 | 14.90M | -1.97% |
Mar 18, 2024 | 15.20M | 7.80% |
Mar 15, 2024 | 14.10M | -1.40% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Precipio | 9.25M |
Galera Therapeutics | 9.25M |
ProSomnus | 9.11M |
Adial Pharmaceuticals | 9.08M |
Molecular Templates | 8.92M |
BioRestorative Therapies | 8.87M |
Fresh2 Group | 8.87M |
Hepion Pharmaceuticals | 8.85M |